Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Mcl-1.

Jorg Michels¹, Peter W M Johnson, Graham Packham

¹Cancer Research UK Oncology Unit, The Somers Cancer Research Building (MP824), University of Southampton School of Medicine, Southampton General Hospital, Southampton SO16 6YD, UK.

The International Journal of Biochemistry & Cell Biology

|October 12, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial.

Blood·2025

Same author

CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

Same author

Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older Patients.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

Same author

PET-Based Risk Stratification in Primary Mediastinal B-Cell Lymphoma: A Comparative Analysis of Different Segmentation Methods in the IELSG37 Trial Patient Cohort.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025

Same author

Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024

Same author

Exploring 2-Sulfonylpyrimidine Warheads as Acrylamide Surrogates for Targeted Covalent Inhibition: A BTK Story.

Journal of medicinal chemistry·2024

Myeloid cell leukemia 1 (Mcl-1) protein regulates cell death and survival. Understanding Mcl-1

Area of Science:

Cell Biology
Molecular Biology
Biochemistry

Background:

Mcl-1 is a Bcl-2 family protein crucial for apoptosis regulation.
It promotes cell survival by preventing cytochrome c release from mitochondria.
Mcl-1 is a short-lived, highly regulated protein influenced by survival signals and apoptosis.

Purpose of the Study:

To elucidate the critical role of Mcl-1 in life and death decisions.
To explore Mcl-1's involvement in embryonic development and immune system function.
To assess the therapeutic potential of targeting Mcl-1 in various diseases.

Main Methods:

Analysis of Mcl-1 regulation and function.
Investigation of Mcl-1's role in cellular processes.
Review of Mcl-1's involvement in disease pathogenesis.

Related Experiment Videos

Main Results:

Mcl-1 plays a critical role in controlling cellular life and death decisions.
Mcl-1 is essential for embryonic development and immune system function.
Mcl-1 cleavage by caspases during apoptosis generates a cell death-promoting molecule.

Conclusions:

Mcl-1's multifaceted regulation highlights its importance in responding to environmental cues.
Targeting Mcl-1 may offer a therapeutic strategy for cancers, inflammatory, and infectious diseases.
Mcl-1 expression patterns can inform cancer treatment decisions.